Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Qiagen
MedTech
Qiagen 'open for discussion' on shareholder value
Qiagen’s outgoing chief executive told investors the company does not “comment on rumors” as takeover talks swirl around the diagnostics specialist.
Ben Adams
Feb 6, 2026 9:15am
Qiagen CEO to step down as company snaps up Parse Biosciences
Nov 4, 2025 2:22pm
Qiagen, AstraZeneca expand DNA test collaboration beyond cancer
Aug 29, 2024 11:30am
Sophia Genetics adds analytics to Qiagen’s sequencing tests
Mar 1, 2023 2:15pm
Qiagen to develop companion diagnostic for Parkinson's drug
Sep 16, 2022 11:53am
Qiagen joins monkeypox test-making efforts
Aug 16, 2022 3:40pm
